A different class of anticancer medication that works by turning off cancer genes appears to effectively halt the progress of prostate cancer development in experimental animals. The new class of anticancer drugs are called histone deacetylase (HDAC) inhibitors. The new medication prevented mice with a precancerous lesion from getting an advanced prostate cancer.
While receiving the [...]
The list of health problems associated with Bishenol A (a common plastic molecule to which virtually all Americans are exposed) continues to grow:
Bisphenol A has been known to be estrogenic since the mid-1930s. It is used to make polycarbonate plastic as well as dental sealants and a resin coating for food cans [...]
Researchers at Rutgers have demonstrated that using a combination of twowidely used drugs Celebrex (celecoxib) and Lipitor (atorvastatin) blocks the transition of early stage prostate cancer to its more aggressive and deadly stage. The researchers objective was to find a way to indefinitely delay the change in the tumor to an aggressive form (this keeps [...]
